When it comes to restarting HRT after breast cancer, there’s no one-size-fits-all answer, but there are guiding principles. In this brief but important lesson, Nico outlines the key clinical factors to consider: cancer type, treatment timeline, symptom severity, and oncologist collaboration. You’ll also learn how to approach shared decision-making, navigate consent, and determine when it’s safe and ethical to begin therapy again.